Vernal et al., 2004 - Google Patents
Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patientsVernal et al., 2004
View PDF- Document ID
- 8632335426177928338
- Author
- Vernal R
- Chaparro A
- Graumann R
- Puente J
- Valenzuela M
- Gamonal J
- Publication year
- Publication venue
- Journal of periodontology
External Links
Snippet
Background: Receptor activator of nuclear factor κB ligand (RANK‐L) is a cytokine involved in the regulation of osteoclastogenesis in bone remodeling and inflammatory osteolysis. One of the major causes of tooth loss in humans is bone destruction. The aim of our study …
- 210000003731 Gingival Crevicular Fluid 0 title abstract description 49
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vernal et al. | Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients | |
Lu et al. | Identification of the osteoprotegerin/receptor activator of nuclear factor‐kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis | |
Vieira Ribeiro et al. | Cytokines and bone‐related factors in systemically healthy patients with chronic periodontitis and patients with type 2 diabetes and chronic periodontitis | |
Rakic et al. | Estimation of bone loss biomarkers as a diagnostic tool for peri‐implantitis | |
Liu et al. | Relationships between clinical parameters, Interleukin 1B and histopathologic findings of gingival tissue in periodontitis patients | |
Salvi et al. | Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin‐dependent diabetes mellitus patients | |
Novak et al. | Immune mechanisms leading to atopic dermatitis | |
Gamonal et al. | Levels of interleukin‐1β,‐8, and‐10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment | |
Shimizu et al. | Cyclic-tension force stimulates interleukin-1β production by human periodontal ligament cells. | |
Mogi et al. | Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis | |
Ay et al. | The gingival crevicular fluid levels of interleukin‐11 and interleukin‐17 in patients with aggressive periodontitis | |
Sadeghi et al. | Interleukin-17 and interleukin-23 levels in gingival crevicular fluid of patients with chronic and aggressive periodontitis | |
Peichl et al. | Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. | |
Sarlati et al. | Receptor activator of nuclear factor kappa B ligand and osteoprotegerin levels in gingival crevicular fluid | |
Lyberg | Immunological and metabolical studies in two siblings with Papillon‐Lefèvre syndrome | |
de Mendonça et al. | Tumor necrosis factor‐alpha levels after surgical anti‐infective mechanical therapy for peri‐implantitis: a 12‐month follow‐up | |
Ursarescu et al. | The assessment of Il-6 and RANKL in the association between chronic periodontitis and osteoporosis | |
Behfarnia et al. | Comparative evaluation of IFNγ, IL4 and IL17 cytokines in healthy gingiva and moderate to advanced chronic periodontitis | |
Okada et al. | Diagnostic strategies of periodontitis based on the molecular mechanisms of periodontal tissue destruction | |
Emingil et al. | Levels of platelet‐activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases | |
Vahabi et al. | Correlation between interleukin-1β, interleukin-6 and tumor necrosis factor-α and clinical parameters in chronic and aggressive periodontal disease | |
Nieminen et al. | Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis | |
WO1990009589A1 (en) | Method for diagnosis of periodontal disease by detection of alanine aminotransferase | |
Yongchaitrakul et al. | Human periodontal ligament cells secrete macrophage colony‐stimulating factor in response to tumor necrosis factor‐alpha in vitro | |
Vernal Astudillo et al. | Levels of cytokine receptor activator of nuclear factor κB ligand in gingival crevicular fluid in untreated chronic periodontitis patients |